Topic: United States
PARIS/LONDON (Reuters) - Regulatory pressure prompted Sanofi-Aventis and Merck & Co to abandon plans for a joint animal health powerhouse with $5 billion in sales.The move sets back the French and U.S. drugmakers' plans to achieve economies of scale in the consolidating ...
CHICAGO (Reuters) - Researchers have used patients' own cells to grow urinary tubes in the lab and have successfully used them to replace damaged tissue in five young boys, showing the potential power of cell-based therapies.Urine flow tests and tube diameter measurements ...
WASHINGTON (Reuters) - Prescription ulcer drugs such as AstraZeneca Plc's blockbuster, Nexium, will carry a new warning that long-term use may cause low magnesium levels, U.S. health officials said on Wednesday.Low magnesium can lead to complications such as muscle spasms, irregular heartbeat ...
SHOHAM, Israel (Reuters) - Teva Pharmaceutical Industries, the world's largest generics drugmaker, said it stands to benefit from the Obama administration's healthcare reform and other plans aimed at getting cheaper medicines to the U.S. market."The healthcare reform and biologics reform are going ...
Japan's Fujifilm, which has been diversifying into healthcare, Monday said it would buy US and British biopharmaceutical companies from America's Merck for a reported half a billion dollars.The Japanese film and camera maker said that it would buy all shares of Diosynth ...
COPENHAGEN (Reuters) - Denmark's Novo Nordisk said on Wednesday it had received a subpoena in the United States regarding potential criminal offences relating to marketing and promotion practices for a number of its products.The world's biggest maker of insulin said in a ...
PARIS (Reuters) - French drugmaker Sanofi-Aventis reported progress in talks to buy U.S. biotech firm as it predicted 5-10 percent lower earnings this year."As we announced about 10 days ago, we have signed a confidentiality agreement with Genzyme," Chief Executive Chris Viehbacher ...
NEW YORK (Reuters) - Pfizer Inc cut its sales projection for 2012, the first full year its $10 billion-a-year Lipitor cholesterol fighter faces competition from cheaper U.S. generics, sending its shares 1.5 percent lower in premarket trading.The world's biggest drugmaker said it ...
MUMBAI (Reuters) - India's No.2 drugmaker Dr Reddy's Laboratories Ltd said on Monday a U.S. district court has cleared the sale of its generic version of Sanofi-Aventis' allergy treatment drug Allegra D24.The U.S. District Court of New Jersey lifted an injunction passed ...
Anglo-Swedish drugs giant AstraZeneca on Thursday announced a seven percent rise in net profits for 2010 to more than $8 billion (£5 billion), helped by higher sales of its cholesterol treatment Crestor.AstraZeneca said in a statement that group earnings after tax grew ...
Photo Gallery
-
South Korea Koreas Clash
South Korean Foreign Minister Kim Sung-hwan, right, shakes hands with U.S ...AP News - -
Hawks Kings Basketball
Sacramento Kings forward Carl Landry, center, goes to the basket against Atlanta ...AP News - -
Blue Jackets Coyotes Hockey
Columbus Blue Jackets' R.J. Umberger (18) scores a goal against Phoenix ...AP News -
